Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TGM2 | P21980 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL976113 | 0.87 | — | — | |
| SCHEMBL1420931 | 0.76 | ALDH1A1 (0.41) | TSHRALDH1A1FGFR4MAPK1TDP1 | |
| SCHEMBL27961654 | 0.76 | ALDH1A1 (0.43) | TSHRALDH1A1FGFR4MAPK1TDP1 | |
| SCHEMBL2702042 | 0.72 | — | — | |
| SCHEMBL1548739 | 0.72 | — | — | |
| SCHEMBL5138580 | 0.72 | ALDH1A1 (0.40) | TSHRALDH1A1FGFR4MAPK1TDP1 | |
| SCHEMBL2943903 | 0.72 | — | — | |
| SCHEMBL11304863 | 0.72 | ALDH1A1 (0.41) | TSHRALDH1A1FGFR4MAPK1TDP1 | |
| Acrylamide SCHEMBL998819 | 0.71 | ALDH1A1 (0.50) | TSHRALDH1A1FGFR4MAPK1TDP1 | |
| SCHEMBL3315750 | 0.70 | ALDH1A1 (0.43) | TSHRALDH1A1FGFR4MAPK1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2703411-B1 | NANOPARTICLES CONTAINING PH-RESPONSIVE PEPTIDE | TAIHO PHARMACEUTICAL CO LTD (JP) | 2017-10-11 | — | — | EP | disclosed |
| WO-2016200343-A1 | AQUEOUS, THICKENED AND TRANSPARENT BLEACHING COMPOSITIONS | HAYAT KIMYA SANAYI ANONIM SIRKETI (TR) | 2016-12-15 | — | — | WO | disclosed |
| US-9186389-B2 | Nanoparticles containing pH-responsive peptide | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2015-11-17 | — | — | US | disclosed |
| US-20150147369-A1 | Personal Care Compositions That Deposit Solid Hydrophilic Benefit Agents | PROCTER & GAMBLE (US) | 2015-05-28 | — | — | US | disclosed |
| EP-2703411-A1 | NANOPARTICLES CONTAINING pH-RESPONSIVE PEPTIDE | Taiho Pharmaceutical Co., Ltd. (JP) | 2014-03-05 | — | — | EP | disclosed |
| US-20140044778-A1 | NANOPARTICLES CONTAINING pH-RESPONSIVE PEPTIDE | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2014-02-13 | — | — | US | disclosed |
| US-20130259913-A1 | PARTICLES AND PARTICLE GAS SATURATED SOLUTION PROCESSES FOR MAKING SAME | THE PROCTER & GAMBLE COMPANY | 2013-10-03 | — | — | US | disclosed |
| WO-2012141946-A1 | PARTICLES AND PARTICLE GAS SATURATED SOLUTION PROCESSES FOR MAKING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2012-10-18 | — | — | WO | disclosed |
| US-8263058-B2 | Personal care compositions that deposit hydrophilic benefit agents | THE PROCTER & GAMBLE COMPANY (US) | 2012-09-11 | — | — | US | disclosed |
| US-20080033058-A1 | Personal care compositions that deposit hydrophilic benefit agents | STELLA QING | 2008-02-07 | — | — | US | disclosed |
| EP-0950392-B1 | Non-sweating lipsticks | PROCTER & GAMBLE (US) | 2004-12-29 | — | — | EP | disclosed |
| US-6325995-B1 | Lipsticks compositions containing association structures | THE PROCTER & GAMBLE COMPANY | 2001-12-04 | — | — | US | disclosed |
| EP-0725620-B1 | NON-SWEATING LIPSTICKS | PROCTER & GAMBLE (US) | 2001-03-14 | — | — | EP | disclosed |
| EP-0950392-A1 | Non-sweating lipsticks | THE PROCTER & GAMBLE COMPANY (US) | 1999-10-20 | — | — | EP | disclosed |
| US-5843407-A | Non-sweating lipsticks | THE PROCTER & GAMBLE COMPANY (US) | 1998-12-01 | — | — | US | disclosed |
| EP-0660696-B1 | LIPSTICKS | PROCTER & GAMBLE (US) | 1997-01-08 | — | — | EP | disclosed |
| EP-0725620-A1 | NON-SWEATING LIPSTICKS | THE PROCTER & GAMBLE COMPANY (US) | 1996-08-14 | — | — | EP | disclosed |
| EP-0660696-A1 | LIPSTICKS. | PROCTER & GAMBLE (US) | 1995-07-05 | — | — | EP | disclosed |
| WO-1995011000-A1 | NON-SWEATING LIPSTICKS | THE PROCTER & GAMBLE COMPANY (US) | 1995-04-27 | — | — | WO | disclosed |
| WO-1994006400-A1 | LIPSTICKS | THE PROCTER & GAMBLE COMPANY (US) | 1994-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080033058-A1 | Personal care compositions that deposit hydrophilic benefit agents | CUTA, DSG1, PLOD3 | TSHR 3774/4885ALDH1A1 2022/4885FGFR4 2243/4885 |
| US-20150147369-A1 | Personal Care Compositions That Deposit Solid Hydrophilic Benefit Agents | CUTA, LIPA, DSG1 | TSHR 2935/4885ALDH1A1 2116/4885FGFR4 1874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.